Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Role of passive T-cell death in chronic experimental autoimmune encephalomyelitis
Shohreh Issazadeh, Kald Abdallah, Tanuja Chitnis, Anil Chandraker, Andrew D. Wells, Laurence A. Turka, Mohamed H. Sayegh, Samia J. Khoury
Shohreh Issazadeh, Kald Abdallah, Tanuja Chitnis, Anil Chandraker, Andrew D. Wells, Laurence A. Turka, Mohamed H. Sayegh, Samia J. Khoury
View: Text | PDF
Article

Role of passive T-cell death in chronic experimental autoimmune encephalomyelitis

  • Text
  • PDF
Abstract

The mechanisms of chronic disease and recovery from relapses in experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis, are unknown. Deletion of myelin-specific lymphocytes by apoptosis may play a role in termination of the inflammatory response. One pathway of apoptosis is the passive cell death or “cell death by neglect” pathway, which is under the control of the Bcl family of genes. To investigate the role of passive cell death pathway in EAE, we used mice with transgenic expression of the long form of the bcl-x gene (Bcl-xL) targeted to the T-cell lineage. We found that mice transgenic for Bcl-xL have an earlier onset and a more chronic form of EAE induced by myelin oligodendrocyte glycoprotein (MOG) peptide 35–55 compared with wild-type littermate mice. This was not due to an expanded autoreactive cell repertoire. Primed peripheral lymphocytes from Bcl-xL transgenic mice showed increased proliferation and cytokine production to MOG peptide in vitro compared with lymphocytes from wild-type animals. Immunohistologic studies demonstrated increased cellular infiltrates, immunoglobulin precipitation, and demyelination in the Bcl-xL transgenic central nervous system (CNS) compared with controls. There was also a decreased number of apoptotic cells in the CNS of Bcl-xL transgenic mice when compared with littermates at all time points tested. This is the first report of an autoimmune disease model in Bcl-xL transgenic mice. Our data indicate that the passive cell death pathway is important in the pathogenesis of chronic EAE. These findings have implications for understanding the pathogenesis of multiple sclerosis and other autoimmune diseases.

Authors

Shohreh Issazadeh, Kald Abdallah, Tanuja Chitnis, Anil Chandraker, Andrew D. Wells, Laurence A. Turka, Mohamed H. Sayegh, Samia J. Khoury

×

Figure 6

Options: View larger image (or click on image) Download as PowerPoint
Quantitation of TUNEL-positive cells in the CNS of Bcl-xL and wild-type ...
Quantitation of TUNEL-positive cells in the CNS of Bcl-xL and wild-type mice. CNS tissue samples were obtained on days 13–15, 20, and 50 after immunization. Fluorescein-labeled cells were counted at ×20 magnification throughout the sections, the total area of the sections was measured, and the number of positive cells was expressed per 100 mm2 of tissue area. There were significant differences in the number of apoptotic cells at all time points (days 13–15, P = 0.004; day 20, P = 0.0002; day 50, P = 0.0001).

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts